Switzerland-based Neopac introduces child resistant nozzle tube featuring twist cap for unit dose applications in response to proposed consumer product safety guidelines in US

Mathew Kearney

Mathew Kearney

POSTFACH, Switzerland , June 14, 2013 (press release) – In response to the proposed CPSC guidelines (Consumer Product Safety Commission) that were unveiled in early 2012, Neopac has launched a number of initiatives to be prepared for the market needs of Child Resistance.

The first initiative was to test and certify a 25 mm diameter C-R cap with a Polyfoil® tube (20–45ml fill) that has been on the European market for some years. Beyond this 25 mm diameter tube, Neopac foresaw the need for larger sizes: A pilot tool was built for a 50–75ml fill level (30 mm diameter) and a 80–125ml fill level (40 mm diameter). These tubes were tested and certified too.

Unit Dose Twist’n’Use™ C-R

Although the main focus has been the multi-use format, Neopac has developed the Polyfoil® Twist’n’Use C-R tube for unit dose applications. The concept behind this tube is that small fill size solutions have a need to be used only once. For this tube to meet the unit dose concept, the Polyfoil® tube’s orifice is sealed. But with a twist of the cap (it remains on the tube) the product can be dispensed to a very specific area. It was recognized that there will be a need for Child Resistance in this market so a C-R closure was designed and developed at our R&D center in Switzerland. This C-R unit dose package is available in a 13.5 mm (4–6ml fill) diameter and a 16 mm (7–10ml fill) diameter Polyfoil® Twist’n’Use™ tube. Testing of all the C-R tubes was performed by an outside Lab ivm (Institut Verpackungs Marktforschung) in the late Spring of 2012. Certification of all the above C-R tubes was issued in July, 2012.

Latest development: C-R nozzle tip

Not to be satisfied with these options, Neopac is currently developing a multi-use C-R package for the products that use our M-6 nozzle tip neck design. The in house proprietary design of this cap has been completed with the initial samples available for testing this month. We are very excited about the completion of this development and look forward to getting it certified in the near future. Visit us at Pharmapack North America for prototypes: June 18–19, 2013, Booth 515.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.


About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.